2016
DOI: 10.1016/j.talanta.2015.09.029
|View full text |Cite
|
Sign up to set email alerts
|

Chromatographic impurity fingerprinting of genuine and counterfeit Cialis® as a means to compare the discriminating ability of PDA and MS detection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
9
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 24 publications
(9 citation statements)
references
References 17 publications
0
9
0
Order By: Relevance
“…Inertsil ODS-3V Column 250 mm×4.6 mm ID, 5 µm dp [57] Grace Alltima C18 Column 250 mm×3 mm ID, 5 µm dp [58] Macherey-Nagel Nucleosil C18 Column 150 mm×4.6 mm ID, 5 µm dp…”
Section: Gl Sciencesmentioning
confidence: 99%
“…Inertsil ODS-3V Column 250 mm×4.6 mm ID, 5 µm dp [57] Grace Alltima C18 Column 250 mm×3 mm ID, 5 µm dp [58] Macherey-Nagel Nucleosil C18 Column 150 mm×4.6 mm ID, 5 µm dp…”
Section: Gl Sciencesmentioning
confidence: 99%
“…[3][4][5] For this purpose, the techniques that have been proposed are generally classified into chromatographic and spectroscopic methods. [6][7][8] Spectroscopic techniques present the advantage to be often non-destructive, the need of little sample preparation and short time analysis. In general, these methods are preferred for the identification of counterfeit drugs or to achieve high sample throughput.…”
Section: Introductionmentioning
confidence: 99%
“…In general, these methods are preferred for the identification of counterfeit drugs or to achieve high sample throughput. [7,9] In regard to spectroscopy, the high suitability of nuclear magnetic resonance spectroscopy (NMR) for a quality assessment of drugs and excipients has been reported. Moreover, quantitative NMR (qNMR) has been indicated as appropriate for quantification of the components without previous separation.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Thus, they can be adopted to identify substandard products. Possible issues include 1) out-of-specification content of active pharmaceutical ingredient (API), 24,25 2) significant dissolution delay, 24 3) contamination with toxic substances, 26,27 and 4) lack of sterility. 28,29 These points can be checked by means of assay, content uniformity testing, measurements of dissolution properties and impurities, and microbial tests.…”
Section: Introductionmentioning
confidence: 99%